NOT-DK-18-022: Notice of Expiration of PA-18-891, Elucidating the Role of the Autonomic Nervous System in Peripheral Metabolism and Metabolic Disease through the Application of Novel Tools and Methodologies (RC2 Clinical Trial Optional)

Notice of Expiration of PA-18-891, Elucidating the Role of the Autonomic Nervous System in Peripheral Metabolism and Metabolic Disease through the Application of Novel Tools and Methodologies (RC2 Clinical Trial Optional)

Notice Number: NOT-DK-18-022

Key Dates
Release Date: August 9, 2018

Related Announcements
PA-18-891

Issued by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

The purpose of this Notice is to announce the expiration of PA-18-891, Elucidating the Role of the Autonomic Nervous System in Peripheral Metabolism and Metabolic Disease through the Application of Novel Tools and Methodologies (RC2 Clinical Trial Optional), effective immediately. This Funding Opportunity Announcement (FOA) will be published under a new FOA Number, PAR-18-898 , Elucidating the Role of the Autonomic Nervous System in Peripheral Metabolism and Metabolic Disease through the Application of Novel Tools and Methodologies (RC2 Clinical Trial Optional).

Inquiries

Please direct all inquiries to:

Karen Teff, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-594-8803
Email: karen.teff@nih.gov